Michael S Bodnar
Overview
Explore the profile of Michael S Bodnar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
18
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bodnar M, Barber S, Jim H, Huang J
J Anesth Transl Med
. 2025 Jan;
3(4):155-165.
PMID: 39872209
Depression and pain are common comorbidities in cancer patients, and ketamine, a dissociative anesthetic, has shown potential in managing both. This review summarizes current literature on ketamine and its enantiomer,...
2.
Wright B, Bodnar M, Moore A, Maseda M, Kucharik M, Diaz C, et al.
Bone Jt Open
. 2024 Feb;
5(2):139-146.
PMID: 38354748
Aims: While internet search engines have been the primary information source for patients' questions, artificial intelligence large language models like ChatGPT are trending towards becoming the new primary source. The...
3.
Murphy B, Terrell E, Chirasani V, Weiss T, Lew R, Holderbaum A, et al.
Nat Commun
. 2022 Jun;
13(1):3153.
PMID: 35672316
A distinct profile of NRAS mutants is observed in each tumor type. It is unclear whether these profiles are determined by mutagenic events or functional differences between NRAS oncoproteins. Here,...
4.
Galloway J, Holderbaum A, Arya N, Zhang S, Bodnar M, Norman R, et al.
Aging Cancer
. 2021 Aug;
1(1-4):58-70.
PMID: 34337428
Background: The impact of biologic aging on immune checkpoint inhibitor (ICI) toxicity and efficacy is underexplored in metastatic melanoma (MM). In peripheral blood T-lymphocytes (PBTLs), biologic aging is characterized by...